Literature DB >> 24615658

Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?

R Michael Tuttle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24615658     DOI： 10.1007/s12020-014-0213-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  7 in total

1.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568

2.  Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients.

Authors:  Maria Grazia Castagna; Fabio Maino; Claudia Cipri; Valentina Belardini; Alexandra Theodoropoulou; Gabriele Cevenini; Furio Pacini
Journal:  Eur J Endocrinol       Date:  2011-07-12       Impact factor: 6.664

Review 3.  A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

Authors:  E L Mazzaferri; R J Robbins; C A Spencer; L E Braverman; F Pacini; L Wartofsky; B R Haugen; S I Sherman; D S Cooper; G D Braunstein; S Lee; T F Davies; B M Arafah; P W Ladenson; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.

Authors:  Fernanda Vaisman; Denise Momesso; Daniel A Bulzico; Cencita H C N Pessoa; Fernando Dias; Rossana Corbo; Mário Vaisman; R Michael Tuttle
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

5.  In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response.

Authors:  Fernanda Vaisman; Hernan Tala; Ravinder Grewal; R Michael Tuttle
Journal:  Thyroid       Date:  2011-12       Impact factor: 6.568

Review 6.  Contemporary post surgical management of differentiated thyroid carcinoma.

Authors:  H Tala; R M Tuttle
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-06-01       Impact factor: 4.126

7.  Biochemical persistence in thyroid cancer: is there anything to worry about?

Authors:  Fabián Pitoia; Pitoia Fabián; Erika Abelleira; Abelleira Erika; Hernán Tala; Tala Hernán; Fernanda Bueno; Bueno Fernanda; Carolina Urciuoli; Urciuoli Carolina; Graciela Cross; Cross Graciela
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633
  7 in total
  6 in total

1.  Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.

Authors:  Soo Young Kim; Bup-Woo Kim; Ju Yeon Pyo; Soon Won Hong; Hang-Seok Chang; Cheong Soo Park
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

2.  Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.

Authors:  Fabián Pitoia; Fernando Jerkovich; Anabella Smulever; Gabriela Brenta; Fernanda Bueno; Graciela Cross
Journal:  Eur Thyroid J       Date:  2017-01-07

3.  Papillary thyroid carcinoma: different clinical behavior among pT3 tumors.

Authors:  Maria Joana Santos; Maria João Bugalho
Journal:  Endocrine       Date:  2016-03-21       Impact factor: 3.633

4.  Effectiveness of Lymphatic Contrast Enhanced Ultrasound in the diagnosis of Cervical Lymph node metastasis from papillary thyroid carcinoma.

Authors:  Ying Wei; Yun Niu; Zhen-Long Zhao; Xiao-Jing Cao; Li-Li Peng; Yan Li; Ming-An Yu
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

5.  Clinical-Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma.

Authors:  Anello Marcello Poma; Elisabetta Macerola; Agnese Proietti; Paola Vignali; Rebecca Sparavelli; Liborio Torregrossa; Antonio Matrone; Alessio Basolo; Rossella Elisei; Ferruccio Santini; Clara Ugolini
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-02       Impact factor: 5.555

6.  Nomogram for the Prediction of Biochemical Incomplete Response in Papillary Thyroid Cancer Patients.

Authors:  Seung Taek Lim; Ye Won Jeon; Hongki Gwak; Ja Seong Bae; Young Jin Suh
Journal:  Cancer Manag Res       Date:  2021-07-13       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.